Archival Issues
Volume 19, 2017
Volume 18, 2016
Volume 17, 2015
Volume 16, 2014
Volume 15, 2013
Volume 14, 2012
Volume 13, 2011
Volume 12, 2010
Volume 11, 2009
Volume 10, 2008
Volume 9, 2007
Volume 8, 2006
Volume 7, 2005
Volume 6, 2004
Volume 5, 2003
Volume 4, 2002
Volume 3, 2001
Volume 2, 2000
Volume 1, 1999
Journal Abstract
Heterotopic ossification in patients after total hip replacement
Tomasz Stołtny, Bogdan Koczy, Wojciech Wawrzynek, Leszek Miszczyk
Ortop Traumatol Rehabil 2007; 9(3):264-272
ICID: 496880
Article type: Review article
IC™ Value: 5.70
Abstract provided by Publisher
Heterotopic ossification (HO) is defined as pathological bone formation in soft tissues, for example in muscles, where physiologically there is no osseous tissue present. It is one of the most common complications of total hip joint replacement surgery. A wide variety of risk factors for heterotopic ossification have been identified to date. Almost 90% of total hip arthroplasty patients are at high risk for HO. There are two primary methods of preventing heterotopic ossification: pharmacotherapy with NSAIDs (non steroid anti-inflammatory drugs) and radiotherapy. Symptomatic heterotopic ossifications are treated by extracorporeal shock wave therapy (ESWT) and surgery, followed by NSAID pharmacotherapy or radiotherapy. The arterioles adjacent to areas of heterotopic ossification are usually embolized prior to the operation. This article describes the state of the art in the prevention and treatment of heterotopic ossifications based on the available literature.

ICID 496880
PMID 17721424 - click here to show this article in PubMed

Related articles
  • in IndexCopernicus™
         kostnienie pozaszkieletowe [1 related records]
         complications [209 related records]
         total hip replacement [19 related records]
         heterotopic ossification [5 related records]

  • Related articlesin PubMed database
  • in PubMed database [ related records]


    Copyright © Ortopedia Traumatologia Rehabilitacja  2017
    Page created by Index Copernicus Ltd. All Rights reserved.